Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

Subsequent Events
9 Months Ended
Sep. 30, 2015
Subsequent Events [Abstract]  
Subsequent Events
14. Subsequent Events
In October 2015, the Company provided an additional $50,000 of working capital to CB Pharma Acquisition Corp.
On October 30, 2015, a subsidiary of Fortress closed the second tranche of a confidential private placement offering raising approximately $12.6 million. Expenses associated with this tranche approximated $1.3 million .